Home / Companies / Nanostring Technologies

Nanostring Technologies

FDA Regulatory Profile

Nanostring Technologies appears in FDA public data with 0 recalls, 2 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on November 7, 2014.

Summary

Total Recalls
0
510(k) Clearances
2
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K141771PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAYNovember 7, 2014
K130010PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAYSeptember 6, 2013

FDA data resources